A1RG34:BVMF
Argenx Se Bdr
R$ १८७.३८
arrow_upward
+१.९९%(+३.६५) 1D
अक्टोबर ६, १६:५६:०० GMT-३ · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for A1RG34...
Open
R$ १८७.३८
High
R$ १८७.३८
Low
R$ १८७.३८
Mkt. cap
५८.४५ अरब
Avg. vol.
५७.००
Volume
१०.००
52-wk high
R$ २१३.१५
52-wk low
R$ १४३.२२
Shares outstanding
६.२६ करोड
No. of employees
२ हजार
Open
R$ १८७.३८
High
R$ १८७.३८
Low
R$ १८७.३८
Mkt. cap
५८.४५ अरब
Avg. vol.
५७.००
Volume
१०.००
52-wk high
R$ २१३.१५
52-wk low
R$ १४३.२२
Shares outstanding
६.२६ करोड
No. of employees
२ हजार
News stories
From web sources and news partners
Investing.com Canada
·
१ घण्टा पहिले
Halozyme expands argenx collaboration with two new targets By Investing.com
Yahoo Finance
·
१ घण्टा पहिले
Halozyme Announces Expansion of Global Collaboration and License Agreement with argenx to Support the Development of Subcutaneous Formulations for Two Additional Exclusive Targets Using its ENHANZE® Technology
AD HOC NEWS
·
५ घण्टा पहिले
argenx stock: New VYVGART data span myasthenia gravis and CIDP
AD HOC NEWS
·
१ दिन पहिले
Argenx stock gets fresh VYVGART data before Q3 results
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About Argenx Se Bdr